{"transactions":[{"id":683399,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-18T22:27:46.000Z","date":"2026-08-15","kind":"grant","planned":false,"acquired":true,"shares":215517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are subject to a deferred stock unit (DSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan and will vest on August 15, 2027, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date. The settlement of the vested shares underlying the DSU award has been deferred and will occur at a later date pursuant to the terms of the DSU award agreement. Each DSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 681,087 shares issuable upon settlement of DSUs granted under the Xtant Medial Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of Xtant through the respective vesting date."}],"balance_after":1129633,"source":{"system":"sec-edgar","filing":"0001183553-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000118355326000001/primary_doc.xml","form_type":"4"}},{"id":771650,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T01:00:11.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the issuer's Common Stock issuable upon settlement of the RSUs until the earlier of (a) a change in control, (b) the Reporting Person's separation of service to the Issuer, or (c) the fifth anniversary of the RSU's grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,000 restricted stock units."}],"balance_after":204056,"source":{"system":"sec-edgar","filing":"0001193125-26-231466","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000119312526231466/ownership.xml","form_type":"4"}},{"id":995600,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-18T22:53:42.000Z","date":"2025-11-15","kind":"grant","planned":false,"acquired":true,"shares":158228,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are subject to a deferred stock unit (DSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan and will vest on November 15, 2026, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date. The settlement of the vested shares underlying the DSU award has been deferred and will occur at a later date pursuant to the terms of the DSU award agreement. Each DSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 465,570 shares issuable upon settlement of DSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of Xtant through the respective vesting dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The purpose of this Form 4 amendment is to correct the number of shares beneficially held in column 5."}],"balance_after":914116,"source":{"system":"sec-edgar","filing":"0001183553-25-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000118355325000006/primary_doc.xml","form_type":"4/A","original_submission_date":"2025-11-15"}},{"id":995597,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-18T22:15:03.000Z","date":"2025-11-15","kind":"grant","planned":false,"acquired":true,"shares":158228,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are subject to a deferred stock unit (DSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan and will vest on November 15, 2026, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date. The settlement of the vested shares underlying the DSU award has been deferred and will occur at a later date pursuant to the terms of the DSU award agreement. Each DSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 465,570 shares issuable upon settlement of DSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of Xtant through the respective vesting dates."}],"balance_after":158228,"source":{"system":"sec-edgar","filing":"0001183553-25-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000118355325000005/primary_doc.xml","form_type":"4"}},{"id":1138848,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T21:30:04.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":23917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 20, 2026 or (b) the date of the 2026 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the issuer's Common Stock issuable upon settlement of the RSUs until the earlier of (a) a change in control, (b) the Reporting Person's separation of service to the Issuer, or (c) the fifth anniversary of the RSU's grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 23,917 restricted stock units."}],"balance_after":174056,"source":{"system":"sec-edgar","filing":"0000950170-25-075888","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000095017025075888/ownership.xml","form_type":"4"}},{"id":1429245,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-19T20:32:25.000Z","date":"2024-08-15","kind":"grant","planned":false,"acquired":true,"shares":162162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are subject to a deferred stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, and vest on August 15, 2025, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 307,342 shares issuable upon settlement of deferred stock units granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of Xtant through the respective vesting dates."}],"balance_after":755888,"source":{"system":"sec-edgar","filing":"0001235802-24-000067","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000123580224000067/primary_doc.xml","form_type":"4"}},{"id":1505265,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-22T21:30:15.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":33260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest in 12 substantially equal monthly installments, commencing on June 21, 2024, such that the stock option will be fully vested and exercisable on the earlier of (a) May 21, 2025, or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":33260,"derivative":{"exercise_price":4.97,"expiration_date":"2034-05-21","underlying":"Common Stock","underlying_shares":33260},"source":{"system":"sec-edgar","filing":"0000950170-24-063617","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000095017024063617/ownership.xml","form_type":"4"}},{"id":1505264,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-22T21:30:15.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":15091,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 21, 2025 or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the issuer's Common Stock issuable upon settlement of the RSUs until the earlier of (a) a change in control, (b) the Reporting Person's separation of service to the Issuer, or (c) the fifth anniversary of the RSU's grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,091 restricted stock units."}],"balance_after":150139,"source":{"system":"sec-edgar","filing":"0000950170-24-063617","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000095017024063617/ownership.xml","form_type":"4"}},{"id":1518950,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-13T23:30:01.000Z","date":"2024-05-10","kind":"purchase","planned":false,"acquired":true,"shares":130000,"price":4.574,"value":594620.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.425 to $4.6186, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,753 restricted stock units."}],"balance_after":135048,"source":{"system":"sec-edgar","filing":"0000950170-24-058974","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000095017024058974/ownership.xml","form_type":"4"}},{"id":1803467,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-17T20:10:46.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":28230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests on August 15, 2024, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date."}],"balance_after":28230,"derivative":{"exercise_price":1.2,"expiration_date":"2033-08-15","underlying":"Common Stock","underlying_shares":28230},"source":{"system":"sec-edgar","filing":"0001235802-23-000090","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000123580223000090/primary_doc.xml","form_type":"4"}},{"id":1803466,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-17T20:10:46.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":145180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are subject to a deferred stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, and vest on August 15, 2024, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 145,180 shares issuable upon settlement of deferred stock units granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date."}],"balance_after":593726,"source":{"system":"sec-edgar","filing":"0001235802-23-000090","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000123580223000090/primary_doc.xml","form_type":"4"}},{"id":1876198,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-26T20:10:40.000Z","date":"2023-05-25","kind":"grant","planned":true,"acquired":true,"shares":36364,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents an RSU award that vests on the earlier of (a) May 23, 2024, or (b) the reporting person's Board-approved separation of service from the Issuer, in each case subject to continuous service of the reporting person through such date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":114352,"source":{"system":"sec-edgar","filing":"0001062993-23-012301","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000106299323012301/form4.xml","form_type":"4"}},{"id":1876197,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-26T20:10:40.000Z","date":"2023-05-24","kind":"sale","planned":true,"acquired":false,"shares":14400,"price":2.7,"value":38880.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were pursuant to a 10b5-1 plan validly adopted by the reporting person to cover the reporting person's tax liability from a restricted stock unit (\"RSU\") award vesting on May 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.60 to $2.77. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":77988,"source":{"system":"sec-edgar","filing":"0001062993-23-012301","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000106299323012301/form4.xml","form_type":"4"}},{"id":1877831,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-26T01:00:21.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":6305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest in 12 substantially equal monthly installments, commencing on June 23, 2023, such that the stock option will be fully vested and exercisable on the earlier of (a) May 23, 2024, or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":6305,"derivative":{"exercise_price":26.34,"expiration_date":"2033-05-23","underlying":"Common Stock","underlying_shares":6305},"source":{"system":"sec-edgar","filing":"0001209191-23-032354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000120919123032354/doc4.xml","form_type":"4"}},{"id":1877830,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-26T01:00:21.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":2753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 23, 2024 or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date.  The Reporting Person voluntarily elected to defer receipt of the shares of the issuer's Common Stock issuable upon settlement of the RSUs until the earlier of (a) a change in control, (b) the Reporting Person's separation of service to the Issuer, or (c) the fifth anniversary of the RSU's grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,753 RSUs."}],"balance_after":5048,"source":{"system":"sec-edgar","filing":"0001209191-23-032354","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000120919123032354/doc4.xml","form_type":"4"}},{"id":2181516,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.000001 par value","published_at":"2022-08-17T20:37:40.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":215415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are subject to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, and vest and become issuable on August 15, 2023, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 215,415 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, conditioned upon the reporting person remaining a director of Xtant through the vesting date."}],"balance_after":448546,"source":{"system":"sec-edgar","filing":"0001235802-22-000097","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000123580222000097/primary_doc.xml","form_type":"4"}},{"id":2251083,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-31T20:29:28.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":38910,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests on the earlier of (a) May 26, 2023, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects an adjustment to total holdings to include 4,050 shares that were reported on a Form 3/A filed on August 20, 2020 but inadvertently omitted from subsequent reports."}],"balance_after":92388,"source":{"system":"sec-edgar","filing":"0001062993-22-013871","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000106299322013871/form4.xml","form_type":"4"}},{"id":2263414,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-20T00:33:14.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":16625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in 12 substantially equal monthly installments, commencing on June 17, 2022, such that the stock option will be fully vested and exercisable on May 17, 2023, subject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":16625,"derivative":{"exercise_price":15.8,"expiration_date":"2032-05-17","underlying":"Common Stock","underlying_shares":16625},"source":{"system":"sec-edgar","filing":"0001567619-22-011340","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000156761922011340/doc1.xml","form_type":"4"}},{"id":2263413,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-20T00:33:14.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":2295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on May 17, 2023 subject to Reporting Person's providing continued service to Issuer through the vesting date."}],"balance_after":2295,"source":{"system":"sec-edgar","filing":"0001567619-22-011340","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000156761922011340/doc1.xml","form_type":"4"}},{"id":2401278,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-11T21:27:56.000Z","date":"2021-10-06","kind":"grant","acquired":true,"shares":92300,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"John K. Bakewell, as Trustee of family trust #2"},"balance_after":92300,"source":{"system":"sec-edgar","filing":"0001567619-22-003544","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000156761922003544/doc1.xml","form_type":"5"}},{"id":2401277,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-11T21:27:56.000Z","date":"2021-10-06","kind":"gift","acquired":false,"shares":92300,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Deborah M. Bakewell"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by the Reporting Person's wife."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-003544","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000156761922003544/doc1.xml","form_type":"5"}},{"id":2401276,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-11T21:27:56.000Z","date":"2021-10-06","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Deborah M. Bakewell, as Trustee of family trust #1"},"balance_after":250000,"source":{"system":"sec-edgar","filing":"0001567619-22-003544","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000156761922003544/doc1.xml","form_type":"5"}},{"id":2401275,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-11T21:27:56.000Z","date":"2021-10-06","kind":"gift","acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-003544","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000156761922003544/doc1.xml","form_type":"5"}},{"id":2401274,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-11T21:27:56.000Z","date":"2021-08-11","kind":"gift","acquired":true,"shares":92300,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Deborah M. Bakewell"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by the Reporting Person's wife."}],"balance_after":92300,"source":{"system":"sec-edgar","filing":"0001567619-22-003544","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000156761922003544/doc1.xml","form_type":"5"}},{"id":2401273,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-11T21:27:56.000Z","date":"2021-08-11","kind":"gift","acquired":false,"shares":92300,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"John K. Bakewell and Deborah M. Bakewell, Co-Owners with Rights of Survivorship"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-003544","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000156761922003544/doc1.xml","form_type":"5"}},{"id":2401272,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-11T21:27:56.000Z","date":"2021-08-11","kind":"gift","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":250000,"source":{"system":"sec-edgar","filing":"0001567619-22-003544","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000156761922003544/doc1.xml","form_type":"5"}},{"id":2401271,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-11T21:27:56.000Z","date":"2021-08-11","kind":"gift","acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"John K. Bakewell and Deborah M. Bakewell, Co-Owners with Rights of Survivorship"},"balance_after":92300,"source":{"system":"sec-edgar","filing":"0001567619-22-003544","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000156761922003544/doc1.xml","form_type":"5"}},{"id":2599971,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.000001 par value","published_at":"2021-08-17T21:19:37.000Z","date":"2021-08-15","kind":"grant","acquired":true,"shares":85337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are subject to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, and vest and become issuable on August 15, 2022, conditioned upon the reporting person remaining a director of Xtant through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 143,436 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, conditioned upon the reporting person remaining a director of Xtant through the vesting date."}],"balance_after":233131,"source":{"system":"sec-edgar","filing":"0001235802-21-000107","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000123580221000107/primary_doc.xml","form_type":"4"}},{"id":2688710,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-01T22:28:37.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":7137,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests on the earlier of (a) May 27, 2022, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":49428,"source":{"system":"sec-edgar","filing":"0001062993-21-005247","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000106299321005247/form4.xml","form_type":"4"}},{"id":2735704,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Series A Preferred Stock","published_at":"2021-04-30T01:10:53.000Z","date":"2021-04-27","kind":"exercise","acquired":false,"shares":342300,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"John K. Bakewell and Deborah M. Bakewell, Co-Owners with Rights of Survivorship"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":342300},"source":{"system":"sec-edgar","filing":"0000899243-21-017465","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000089924321017465/doc4.xml","form_type":"4"}},{"id":2735703,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Series A Preferred Stock","published_at":"2021-04-30T01:10:53.000Z","date":"2021-04-27","kind":"other","acquired":true,"shares":7925,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"John K. Bakewell and Deborah M. Bakewell, Co-Owners with Rights of Survivorship"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend."}],"balance_after":342300,"derivative":{"underlying":"Common Stock","underlying_shares":7925},"source":{"system":"sec-edgar","filing":"0000899243-21-017465","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000089924321017465/doc4.xml","form_type":"4"}},{"id":2735702,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2021-04-30T01:10:53.000Z","date":"2021-04-27","kind":"exercise","acquired":true,"shares":342300,"ownership":{"direct":false,"nature":"John K. Bakewell and Deborah M. Bakewell, Co-Owners with Rights of Survivorship"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."}],"balance_after":342300,"source":{"system":"sec-edgar","filing":"0000899243-21-017465","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000089924321017465/doc4.xml","form_type":"4"}},{"id":2739469,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Right to Buy","published_at":"2021-04-27T00:55:45.000Z","date":"2021-04-22","kind":"grant","acquired":true,"shares":21240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in 12 substantially equal installments, commencing on May 22, 2021, such that the stock option will be fully vested and exercisable on April 22, 2022, subject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":21240,"derivative":{"exercise_price":17,"expiration_date":"2031-04-22","underlying":"Common Stock","underlying_shares":21240},"source":{"system":"sec-edgar","filing":"0000899243-21-017024","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000089924321017024/doc4.xml","form_type":"4"}},{"id":3064594,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-07T21:14:07.000Z","date":"2020-08-05","kind":"grant","acquired":true,"shares":12291,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests on the earlier of (a) August 5, 2021, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":42291,"source":{"system":"sec-edgar","filing":"0001192482-20-000648","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000119248220000648/edgar.xml","form_type":"4"}},{"id":3131958,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-28T20:15:53.000Z","date":"2020-05-26","kind":"grant","acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests on the earlier of (a) May 26, 2021, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001192482-20-000401","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000119248220000401/edgar.xml","form_type":"4"}},{"id":3284428,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.000001 par value","published_at":"2020-02-07T21:12:14.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":116197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are subject to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, and will vest and become issuable with respect 58,098 shares on February 15, 2021 and with respect to 58,099 shares on February 15, 2022, conditioned upon the reporting person remaining a director of Xtant through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 116,197 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, conditioned upon the reporting person remaining a director of Xtant through the vesting date; (ii) 5,555 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, conditioned upon the reporting person remaining a director of Xtant through the vesting date, and (iii) 13,021 shares issued as part of a restricted stock award granted under the Amended and Restated Xtant Equity Incentive Plan, which shares are subject to forfeiture until vested."}],"balance_after":147794,"source":{"system":"sec-edgar","filing":"0001235802-20-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000123580220000003/primary_doc.xml","form_type":"4"}},{"id":3406520,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.000001 par value","published_at":"2019-09-25T20:36:53.000Z","date":"2019-09-24","kind":"grant","acquired":true,"shares":5555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are subject to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan and will vest and become issuable on February 15, 2020, conditioned upon the reporting person remaining a director of Xtant through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,555 shares to be issued upon vesting pursuant to restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, conditioned upon the reporting person remaining a director of Xtant through the vesting date, and 13,021 shares issued as part of a restricted stock award granted under the Amended and Restated Xtant Equity Incentive Plan, which shares are subject to forfeiture until vested."}],"balance_after":31597,"source":{"system":"sec-edgar","filing":"0001235802-19-000122","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000123580219000122/primary_doc.xml","form_type":"4"}},{"id":3966125,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-10T23:00:42.000Z","date":"2018-04-09","kind":"grant","acquired":true,"shares":26042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock vests as follows: (i) 13,021 shares of common stock vests on February 15, 2019, and (ii) 13,021 shares of common stock vests of February 15, 2020."}],"balance_after":26042,"source":{"system":"sec-edgar","filing":"0001144204-18-020004","document":"tv490829_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000114420418020004/tv490829_4.xml","form_type":"4"}},{"id":4010448,"issuer":{"id":154132,"kind":"organization","name":"Corindus Vascular Robotics, Inc.","symbol":"CVRS"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-07T00:00:28.000Z","date":"2017-12-15","kind":"grant","acquired":true,"shares":32072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The common stock represents shares issuable upon vesting of restricted stock units granted as part of the director's annual equity award. The RSUs were initially vested with respect to one quarter of the granted units. The remaining quarterly installments will vest on February 8, 2018, May 8, 2018 and August 8, 2018, subject to the reporting person's continuous service with Corindus Vascular Robotics, Inc. through each such vesting date."}],"balance_after":32072,"source":{"system":"sec-edgar","filing":"0001387131-18-000939","document":"bakewell-form4a_121517.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000138713118000939/bakewell-form4a_121517.xml","form_type":"4/A","original_submission_date":"2017-12-19"}},{"id":4023592,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-01T15:34:22.000Z","date":"2018-02-28","kind":"disposition_to_issuer","acquired":false,"shares":5000,"price":10.62,"value":53100.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, which provided for vesting in full on the earlier of June 13, 2018 and the date of the annual stockholder meeting following June 13, 2017, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option."}],"balance_after":0,"derivative":{"exercise_price":13.38,"expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001235802-18-000029","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580218000029/primary_doc.xml","form_type":"4"}},{"id":4023591,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-01T15:34:22.000Z","date":"2018-02-28","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":5.74,"value":57400.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, which provided for vesting in full on the earlier of June 14, 2017 and the date of the annual stockholder meeting following June 14, 2016, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option."}],"balance_after":0,"derivative":{"exercise_price":18.26,"expiration_date":"2026-06-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001235802-18-000029","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580218000029/primary_doc.xml","form_type":"4"}},{"id":4023590,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2018-03-01T15:34:22.000Z","date":"2018-02-28","kind":"disposition_to_issuer","acquired":false,"shares":2500,"price":24,"value":60000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to an Agreement and Plan of Merger, dated December 7, 2017, between Entellus Medical, Inc., Stryker Corporation and Explorer Merger Sub Corp. in exchange for a cash payment of $24.00 per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001235802-18-000029","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580218000029/primary_doc.xml","form_type":"4"}},{"id":4126103,"issuer":{"id":154132,"kind":"organization","name":"Corindus Vascular Robotics, Inc.","symbol":"CVRS"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-12-20T01:36:17.000Z","date":"2017-12-15","kind":"grant","acquired":true,"shares":32072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.0001 per share, of Corindus Vascular Robotics, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on December 15, 2017 as part of the director's annual equity award with vesting beginning as of August 8, 2017, the date of the reporting person's appointment as a director. The restricted stock units vest in four equal quarterly installments on November 8, 2017, February 8, 2018, May 8, 2018 and August 8, 2018, subject to the reporting person's continuous service with Corindus Vascular Robotics, Inc. through each such vesting date. Vested shares will be delivered to the reporting person within five days of each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on December 15, 2017 as part of the director's annual equity award with vesting beginning as of August 8, 2017, the date of the reporting person's appointment as a director. The restricted stock units vest in four equal quarterly installments on November 8, 2017, February 8, 2018, May 8, 2018 and August 8, 2018, subject to the reporting person's continuous service with Corindus Vascular Robotics, Inc. through each such vesting date. Vested shares will be delivered to the reporting person within five days of each such vesting date."}],"balance_after":32072,"derivative":{"underlying":"Common Stock","underlying_shares":32072},"source":{"system":"sec-edgar","filing":"0001387131-17-005914","document":"bakewell-form4_121517.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183553/000138713117005914/bakewell-form4_121517.xml","form_type":"4"}},{"id":4282112,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-14T16:04:40.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the earlier to occur of June 13, 2018 and the date of the Company's annual meeting of stockholders immediately following June 13, 2017, subject to the Reporting Person's continued service with the Company through the applicable vesting date."}],"balance_after":5000,"derivative":{"exercise_price":13.38,"expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001235802-17-000079","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580217000079/primary_doc.xml","form_type":"4"}},{"id":4282111,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":22202,"kind":"person","name":"BAKEWELL JOHN K","position":1,"cik":"0001183553","reported_name":"BAKEWELL JOHN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-06-14T16:04:40.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001235802-17-000079","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580217000079/primary_doc.xml","form_type":"4"}}]}